Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Moodys
Farmers Insurance
Boehringer Ingelheim
Cantor Fitzgerald
Federal Trade Commission
US Department of Justice
Julphar

Generated: December 18, 2018

DrugPatentWatch Database Preview

Drug Sales Trends for AMITIZA

« Back to Dashboard

Payment Methods and Pharmacy Types for AMITIZA (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
INSIDE ANOTHER STORE $30,298,678
INSIDE HMO/CLINIC/HOSPITAL $2,663,240
[disabled in preview] $271,382,565
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
INSIDE ANOTHER STORE 112,646
INSIDE HMO/CLINIC/HOSPITAL 15,909
[disabled in preview] 827,201
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $33,770,243
MEDICARE $141,920,948
[disabled in preview] $128,653,293
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for AMITIZA
Drug Units Sold Trends for AMITIZA

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
UBS
Farmers Insurance
US Army
AstraZeneca
Daiichi Sankyo
Accenture
Teva
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.